Desoxypipradrol

The live United States row was reopened from https://glad-minnow-656.convex.cloud and exactly matched the supplied packet metadata. Its legacy statement that desoxypipradrol is not federally scheduled and therefore legal to possess and import is materially overbroad: Texas, New Mexico, Alabama, and Ohio current primary sources expressly control the exact compound, under different state categories. Federally, the current DEA materials provide only a bounded absence check and expressly warn that their lists are not comprehensive. Pipradrol is Schedule IV under 21 C.F.R. § 1308.14(f)(10), while 21 U.S.C. § 802(32)(A) defines an analogue by reference to Schedule I or II substances and § 813 applies Schedule I treatment only to a qualifying analogue intended for human consumption. No current written federal determination applying those criteria to desoxypipradrol was located. The separate import assertion is not established by the inspected sources and is expressly qualified by 21 U.S.C. § 952 if the substance is treated as a covered Schedule I or II substance. The corrected canonical status is restricted_other, recording verified direct state controls together with unresolved federal and nationwide state-law scope; it is not a claim that every state controls the compound or that federal analogue coverage has been decided.

The live Germany row was reopened from glad-minnow-656 and still says status Anlage II BtMG, with the legacy note asserting unlicensed handling is prohibited and retaining a December 13, 2014 date. Current official German primary law confirms the substance is expressly listed as Desoxypipradrol (2-DPMP), 2-(Diphenylmethyl)piperidin in BtMG Anlage II. Anlage II is the regulated marketable-but-not-prescribable category, but BtMG § 1 makes it a Betäubungsmittel, § 3 requires the applicable BfArM permit for the listed traffic routes, and § 29 criminalizes unauthorized handling and possession without a written acquisition permit. The canonical status is therefore corrected to prohibited for ordinary unlicensed possession and handling, while statutory authorization pathways and the limited § 29 Abs. 5 small-quantity own-use discretion remain. NpSG is expressly inapplicable to BtMG narcotics. The current sources establish the operative classification; the legacy 13 December 2014 date was not needed for the current result and is not independently asserted here.

The live Switzerland row was reopened from https://glad-minnow-656.convex.cloud and still says Uncontrolled, with a note limited to non-listing under A–D and a tentative possession conclusion. Current binding Swiss law is the BetmVV-EDI, SR 812.121.11, consolidated as at 13 March 2026. Its Articles 1–2 make Annexes 1–6 the operative controlled-substance lists (a–e). Full inspection and exact-name/CAS searches found no Desoxypipradrol, 2-DPMP, 2-(Diphenylmethyl)piperidine or Pipradrol entry, and the generic Annex 6 classes inspected do not match this scaffold. Diphenylprolinol (D2PM) item 58 is a distinct substance and cannot be used to infer control of desoxypipradrol. The existing generic Uncontrolled label is corrected to the canonical status unscheduled. This is a scheduling conclusion only; it does not assert that every possession, import, sale, formulation or product-safety question is lawful under other Swiss laws, nor does it infer a legal-possession guarantee from non-listing.

The live production row was reopened from https://glad-minnow-656.convex.cloud for slug desoxypipradrol; its China value is status Controlled substance with notes that classification began in October 2015. Fresh current Chinese sources identify the exact substance as entry 105 (2-二苯甲基哌啶 / 2-Diphenylmethylpiperidine / CAS 519-74-4 / 2-DPMP) in the 2025 Catalogue of Non-medical Narcotic Drugs and Psychotropic Substances, displayed in the current national directory updated through 2026-07-01. Under current Article 4, ordinary production, operation, use, storage and transport are prohibited, subject to regulated experimental-research provisions. The October 2015 date and historical entry are supported, but the former supplemental catalogue was repealed and consolidated in 2025; the generic live status is therefore corrected to prohibited. This is a nationwide China classification; no subnational exception was inferred.

The existing Russia claim is substantively supported by the current official Russian consolidated schedule: the exact parent name (Пиперидин-2-ил)дифенилметан is in List I, whose heading states that circulation is prohibited. The publishable status is therefore canonical prohibited; the old English label Schedule I is normalized to the campaign vocabulary, and the designation is expanded to preserve the schedule's derivatives exception. The evidence supports nationwide List I prohibition and does not assert any product-specific prescription or medical exception beyond the statutory List I purposes.

The live production row was reopened from https://glad-minnow-656.convex.cloud and exactly matched the supplied United Kingdom packet (contentHash e8cb34f954a87b911215ec0b5c18fd753e8b5aa3f568b6116edc1e55b62da872). Its existing status label 'Class B, Schedule I' is substantively supported but is not a canonical workflow status. Current primary sources confirm that desoxypipradrol (2-DPMP) is covered by the generic pipradrol-related structural provision in Class B Part II of the Misuse of Drugs Act 1971 and Schedule 1 of the GB and Northern Ireland misuse-of-drugs regulations, effective 13 June 2012. The current Home Office list explicitly gives Class B and Schedule 1. The corrected canonical status is therefore prohibited. The existing 4 November 2010 import-ban date and harm narrative were not needed to establish the current classification and are not repeated as current legal authority; current section 3 supplies the operative import/export rule with its licence exceptions. Separate Schedule 3 treatment of pipradrol esters and ethers does not alter desoxypipradrol's Schedule 1 classification.